Health Care [ 2/12 ] | Health Care Equipment & Supplies [ 36/73 ]
NYSE MKT | Common Stock
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally.
The company offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, which can be compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier.
It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications.
In addition, the company offers cervical products comprising Spider cervical plating, Streamline OCT, and CervAlign systems; thoracolumbar products consisting of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2.0 hybrid performance systems; and Silex sacroiliac joint fusion systems.
Further, it provides interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain.
Xtant Medical Holdings, Inc. is headquartered in Belgrade, Montana.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Oct 30, 25 | 0.00 Increased by +100.00% | -0.01 Increased by +100.00% |
| Aug 12, 25 | 0.02 Increased by +166.67% | -0.01 Increased by +300.00% |
| May 12, 25 | 0.28 Increased by +1.03 K% | -0.01 Increased by +2.89 K% |
| Mar 31, 25 | -0.01 Increased by +55.33% | -0.02 Increased by +33.00% |
| Nov 7, 24 | -0.04 Decreased by -157.14% | -0.02 Decreased by -100.00% |
| Aug 8, 24 | -0.03 Decreased by -50.00% | -0.02 Decreased by -50.00% |
| Apr 1, 24 | -0.03 Decreased by -50.00% | -0.02 Decreased by -50.00% |
| Feb 13, 24 | -0.03 Decreased by -50.00% | -0.02 Decreased by -50.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 25 | 35.41 M Increased by +18.26% | 3.55 M Increased by +191.95% | Increased by +10.03% Increased by +177.75% |
| Mar 31, 25 | 32.90 M Increased by +18.05% | 58.00 K Increased by +101.32% | Increased by +0.18% Increased by +101.12% |
| Dec 31, 24 | 31.51 M Increased by +12.11% | -3.17 M Increased by +26.45% | Decreased by -10.04% Increased by +34.39% |
| Sep 30, 24 | 27.94 M Increased by +11.66% | -5.02 M Decreased by -154.43% | Decreased by -17.98% Decreased by -148.74% |
| Jun 30, 24 | 29.94 M Increased by +48.00% | -3.86 M Decreased by -76.30% | Decreased by -12.89% Decreased by -19.12% |
| Mar 31, 24 | 27.87 M Increased by +55.34% | -4.40 M Decreased by -111.74% | Decreased by -15.79% Decreased by -36.31% |
| Dec 31, 23 | 28.11 M Increased by +84.07% | -4.30 M Decreased by -94.79% | Decreased by -15.31% Decreased by -5.82% |
| Sep 30, 23 | 25.02 M Increased by +73.00% | 9.23 M Increased by +492.31% | Increased by +36.90% Increased by +326.77% |